# Pediatric Tics & Tourette Syndrome: Clinical Cannabinoid Guide | CĒD Clinic > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/pediatrics/tics/ > **Published:** 2026-09-27T18:12:09-04:00 | **Last Modified / Clinically Audited:** 2026-09-27T18:12:09-04:00 > **Clinical Summary:** Home › Pediatric Cannabinoid Medicine › Medical Cannabis for Pediatric Tics & Tourette Syndrome Refractory Movement Disorders PEDIATRIC MOTOR & MOVEMENT DISORDERS Medical Cannabis for Pediatric Tics & Tourette Syndrome Persistent motor and vocal tics in Tourette Syndrome cause physical pain, severe social distress, and cognitive exhaustion. When behavioral Comprehensive Behavioral Intervention for Tics (CBIT) […] --- [Home](https://cedclinic.com/) › [Pediatric Cannabinoid Medicine](https://cedclinic.com/pediatrics/) › [Medical Cannabis](https://cedclinic.com/cbd-gummies-for-sexual-enhancement-evidence/) for Pediatric Tics & Tourette Syndrome Refractory Movement Disorders PEDIATRIC MOTOR & MOVEMENT DISORDERS Table of Contents - [Medical Cannabis for Pediatric Tics & Tourette Syndrome](#Medical_Cannabis_for_Pediatric_Tics_038_Tourette_Syndrome)[When Is Cannabinoid Therapy Appropriate for Pediatric Tics?](#When_Is_Cannabinoid_Therapy_Appropriate_for_Pediatric_Tics) - [The Anatomy of Tic Generation: Premonitory Urges](#The_Anatomy_of_Tic_Generation_Premonitory_Urges) - [Endocannabinoid Regulation of Basal Ganglia Motor Circuits](#Endocannabinoid_Regulation_of_Basal_Ganglia_Motor_Circuits) - [Safe Pediatric Titration & Physician Coordination](#Safe_Pediatric_Titration_038_Physician_Coordination)[Need Expert Clinical Guidance for Your Child?](#Need_Expert_Clinical_Guidance_for_Your_Child) # Medical Cannabis for Pediatric Tics & Tourette Syndrome Persistent motor and vocal tics in Tourette Syndrome cause physical pain, severe social distress, and cognitive exhaustion. When behavioral Comprehensive Behavioral Intervention for Tics (CBIT) and first-line alpha-agonists leave tics uncontrolled, clinical [cannabinoid therapy](https://cedclinic.com/cbd-gummies-libido-enhancement/) can reduce tic frequency and alleviate premonitory urges. Clinical Director: **Benjamin Caplan, MD** Clinical Standard: **Refractory / Treatment-Resistant Cases Only** Oversight: **Frequent Physician Monitoring** ### When Is Cannabinoid Therapy Appropriate for Pediatric Tics? **Clinical Appropriateness Standard:** Cannabinoids are reserved for children and adolescents diagnosed with Tourette Syndrome or chronic motor/vocal tic disorders whose symptoms cause significant functional impairment, pain, or social isolation and have failed to respond adequately to CBIT and conventional medications (such as Clonidine, Guanfacine, or neuroleptics)—or who have suffered intolerable sedation, weight gain, or depression from those drugs. ## The Anatomy of Tic Generation: Premonitory Urges Tics are preceded by an uncomfortable somatic sensation known as a “premonitory urge”—a visceral tension in the neck, throat, eyes, or limbs that intensifies until the motor or vocal release is executed. In pediatric Tourette Syndrome: - Dopaminergic and glutamatergic signaling in the striatum and basal ganglia operate in a state of disinhibition. - Co-occurring conditions—including ADHD, OCD, and sensory processing hypersensitivity—exponentially increase the cognitive burden and frequency of tic flares. - Conventional medications frequently cause severe lethargy, making academic engagement nearly impossible for school-age children. ## Endocannabinoid Regulation of Basal Ganglia Motor Circuits The basal ganglia possess one of the highest densities of cannabinoid CB1 receptors in the entire central nervous system. Clinical investigations (including landmark studies led by Dr. Kirsten Müller-Vahl and international pediatric neurology groups) have established that: - **Dopaminergic Fine-Tuning:** Cannabinoid receptor activation modulates presynaptic neurotransmitter release, dampening the abnormal basal ganglia output that triggers involuntary motor twitches and vocal outbursts. - **Reduction of Premonitory Urge Severity:** By buffering central sensory sensitivity and hyper-reflexive motor impulses, cannabinoids help children tolerate and resist premonitory urges without intense physical discomfort. - **Alleviation of Comorbid Anxiety & Muscular Strain:** Cannabidiol (CBD) and Cannabigerol (CBG) relax chronic cervical and paraspinal muscular spasms caused by repetitive violent head-jerking and motor tics. ## Safe Pediatric Titration & Physician Coordination Pediatric tic protocols prioritize high-purity CBD and CBG oral formulations. When refractory cases require minor amounts of whole-plant synergy, micro-doses are titrated in fractional milligrams under strict clinical observation to ensure zero psychoactive impairment or school performance decline. The CĒD Clinic Clinical Process for Pediatric Patients Cannabinoid medicine is never casual or one-size-fits-all. Every pediatric patient undergoes structured, conservative physician oversight to ensure maximum safety, legal protection, and clinical efficacy. 1 Comprehensive Intake & Records Review We conduct a meticulous review of prior diagnostic evaluations, failed medications, laboratory work, and specialist records. We verify refractory criteria and screen for CYP450 drug-drug interactions. 2 Customized Care Plan & Product Guidance Dr. Caplan formulates an individualized botanical care plan specifying exact cannabinoid ratios (CBD, CBDA, CBG, CBC), administration routes, and verified, third-party lab-tested (COA) products. 3 Conservative Micro-Titration Protocol Therapy begins at low, sub-therapeutic micro-doses. Families log daily symptom metrics using our clinic tracking journals, adjusting dosages gradually every 7 to 14 days under physician supervision. 4 Frequent Oversight & Team Coordination We provide frequent follow-ups, adjust formulations as the child grows, and communicate directly with your child’s primary care pediatrician, neurologist, or psychiatrist to ensure coordinated care. #### Need Expert Clinical Guidance for Your Child? Schedule a confidential consultation to explore whether cannabinoid therapy is appropriate for your family. [Schedule Consultation](https://cedclinic.com/contact/) [← Return to Pediatrics Overview](https://cedclinic.com/pediatrics/) --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).